Ranitidine delays gastric emptying of solids in man.

PubWeight™: 1.26‹?› | Rank: Top 10%

🔗 View Article (PMC 1401998)

Published in Br J Clin Pharmacol on February 01, 1982

Authors

C Scarpignato, G Bertaccini, G Zimbaro, F Vitulo

Articles citing this

Effect of gastric acid suppressants on human gastric motility. Gut (1998) 1.89

Effect of some new H2-receptor antagonists on gastrointestinal motility. Agents Actions (1983) 1.00

Effects of Histamine-2 Receptor Antagonists and Proton Pump Inhibitors on the Rate of Gastric Emptying: A Crossover Study Using a Continuous Real-Time C Breath Test (BreathID System). J Neurogastroenterol Motil (2011) 0.94

Dose and concentration dependent effect of ranitidine on procainamide disposition and renal clearance in man. Br J Clin Pharmacol (1984) 0.94

The effect of omeprazole on gastric emptying in patients with duodenal ulcer disease. Br J Clin Pharmacol (1984) 0.94

Histamine H2-antagonists modify gastric emptying in the rat. Br J Pharmacol (1982) 0.91

Influence of acid-pepsin secretion on gastric emptying of solids in humans: studies with cimetidine. Gut (1991) 0.84

Ranitidine bismuth citrate and ranitidine do not affect gastric emptying of a radio-labelled liquid meal. Br J Clin Pharmacol (1994) 0.82

A comparison of gastric emptying rate after cimetidine and ranitidine measured by applied potential tomography. Br J Clin Pharmacol (1992) 0.80

Effects of rabeprazole sodium on gastric emptying, electrogastrography, and fullness. Dig Dis Sci (2003) 0.79

Ranitidine and nizatidine stimulate antral smooth muscle contractility via excitatory cholinergic mechanisms. Dig Dis Sci (1998) 0.76

Relaxant effect of the H2-receptor antagonist oxmetidine on guinea-pig and human airways. Br J Pharmacol (1987) 0.75

Articles cited by this

Control of gastric emptying and motility. Gastroenterology (1975) 2.14

Ranitidine (AH 19065): a new potent, selective histamine H2-receptor antagonist [proceedings]. Br J Pharmacol (1979) 1.76

New histamine H2-receptor antagonists. Hepatogastroenterology (1980) 1.30

Caerulein delays gastric emptying of solids in man. Arch Int Pharmacodyn Ther (1981) 1.15

Articles by these authors

The actions of caerulein on the smooth muscle of the gastrointestinal tract and the gall bladder. Br J Pharmacol (1968) 1.79

Occurrence of physalaemin in extracts of the skin of Physalaemus fuscumaculatus and its pharmacological actions on extravascular smooth muscle. Br J Pharmacol Chemother (1965) 1.74

Evidence that acetylcholine released by gastrin and related polypeptides contributes to their effect on gastrointestinal motility. Gastroenterology (1973) 1.71

Gastrin release by bombesin in the dog. Br J Pharmacol (1974) 1.67

The burden of constipation on quality of life: results of a multinational survey. Aliment Pharmacol Ther (2007) 1.64

Treatment of gastro-oesophageal reflux disease in adults. BMJ (1998) 1.62

Action of caerulein and related substances on the pyloric sphincter of the anaesthetized rat. Eur J Pharmacol (1973) 1.61

The actions of caerulein on gastric secretion of the dog and the rat. Br J Pharmacol (1968) 1.58

A multinational survey of prevalence and patterns of laxative use among adults with self-defined constipation. Aliment Pharmacol Ther (2008) 1.49

Quality of life for patients with gastroesophageal reflux disease 2 years after laparoscopic fundoplication. Evaluation of the results obtained during the initial experience. Surg Endosc (2002) 1.45

Reflux related symptoms in patients with normal oesophageal exposure to acid. Gut (1995) 1.44

The action of physalaemin on the systemic arterial blood pressure of some experimental animals. Br J Pharmacol Chemother (1965) 1.34

The action of caerulein on the systemic arterial blood pressure of some experimental animals. Br J Pharmacol Chemother (1968) 1.34

Action of caerulein on gastric emptying of the conscious rat. Arch Int Pharmacodyn Ther (1980) 1.29

Tissue 5-hydroxytryptamine and urinary 5-hydroxyindoleacetic acid after partial or total removal of the gastro-intestinal tract in the rat. J Physiol (1960) 1.28

Pharmacological actions of caerulein. Experientia (1967) 1.26

Pharmacological data on phyllokinin (bradykinyl-isoleucyl-tyrosine o-sulphate) and bradykinyl-isoleucyl-tyrosine. Br J Pharmacol Chemother (1966) 1.24

The action of caerulein on pancreatic secretion of the dog and biliary secretion of the dog and the rat. Br J Pharmacol (1969) 1.24

N-methyl, 5-methyl histamine evokes a higher maximal rate of gastric acid secretion than histamine. Proc Soc Exp Biol Med (1977) 1.23

Cholinergic-like effects of the new histamine H2-receptor antagonist ranitidine. Agents Actions (1982) 1.23

Synthetic peptides related to caerulein. 1. Experientia (1968) 1.20

The effect of physalaemin and related polypeptides on salivary secretion. J Physiol (1965) 1.19

Action of the new H2-antagonist, DA 4577, on different in vitro and in vivo preparations. Agents Actions (1984) 1.18

Inhibition of gastric acid secretion in man by peptide analogues of cholecystokinin. N Engl J Med (1970) 1.17

Caerulein delays gastric emptying of solids in man. Arch Int Pharmacodyn Ther (1981) 1.15

Evidence for and against heterogeneity in the histamine H2-receptor population. Pharmacology (1981) 1.14

Can gangrenous cholecystitis be prevented?: a plea against a "wait and see" attitude. J Clin Gastroenterol (2004) 1.13

DNA/protein flow cytometry as a predictive marker of malignancy in dysplasia-free Barrett's esophagus: thirteen-year follow-up study on a cohort of patients. Cytometry (1998) 1.13

Structure and pharmacological actions of physalaemin, the main active polypeptide of the skin of Physalaemus fuscumaculatus. Experientia (1964) 1.11

Effect of histamine and related compounds on the papillary muscle of the guinea pig. Pharmacol Res Commun (1978) 1.09

Cardiac effects of the new H2-receptor antagonists. Agents Actions (1983) 1.08

Editorial: healing of refractory reflux oesophagitis--an ongoing unmet clinical need. Aliment Pharmacol Ther (2014) 1.06

[Effect of H2 histamine receptor blocking agents on the isolated lower esophageal sphincter (LES) of the rat]. Farmaco Sci (1981) 1.06

The effects of stimulants and inhibitors of histamine receptors on acid secretion from guinea pig gastric fundus. Eur J Pharmacol (1978) 1.01

Different effects of the H2-antagonists on gastric emptying in the rat. Experientia (1982) 1.01

Endogenous cholecystokinin in postprandial lower esophageal sphincter function and fundic tone in humans. Am J Physiol (1998) 1.01

Histamine receptors in the heart and coronary vessels of rabbits. Pharmacol Res Commun (1979) 1.00

Effect of some new H2-receptor antagonists on gastrointestinal motility. Agents Actions (1983) 1.00

Regulation of gastric acid secretion by histamine H3 receptors in the dog: an investigation into the site of action. Naunyn Schmiedebergs Arch Pharmacol (1994) 1.00

Dysphagia aortica: a neglected symptom of aortoesophageal fistula. Dig Liver Dis (2006) 0.98

Action of histamine and of some H2-antagonists on gastric secretion 'in vitro'. Agents Actions (1984) 0.96

Presence of caerulein in extracts of the skin of Leptodactylus pentadactylus labyrinthicus and of Xenopus laevis. Br J Pharmacol (1970) 0.96

Effect of impromidine (SK&F 92676) on the isolated papillary muscle of the guinea-pig. Br J Pharmacol (1981) 0.95

The actions of bombesin on gastric secretion of the dog and the rat. Br J Pharmacol (1973) 0.95

Evidence that histamine H3 receptors are involved in the control of gastric acid secretion in the conscious cat. Naunyn Schmiedebergs Arch Pharmacol (1991) 0.94

Histamine H3 receptor-mediated inhibition of gastric acid secretion in conscious dogs. Naunyn Schmiedebergs Arch Pharmacol (1993) 0.94

Active polypeptides of nonmammalian origin. Pharmacol Rev (1976) 0.94

Effects of physalaemin on some exocrine secretions of dogs and rats. J Physiol (1967) 0.94

Structure and pharmacological actions of phyllocaerulein, a caerulein-like nonapeptide: its occurrence in extracts of the skin of Phyllomedusa sauvagei and related Phyllomedusa species. Br J Pharmacol (1969) 0.94

The bronchoconstrictor action of the tetradecapeptide bombesin in the guinea-pig. J Pharm Pharmacol (1973) 0.93

Corrosive oesophageal strictures in children: outcomes after timely or delayed dilatation. Dig Liver Dis (2008) 0.93

Ultrasonography in the early diagnosis of psoriasis-associated enthesopathy. Int J Tissue React (2005) 0.93

Histamine H3 receptors are not involved in the regulation of rat gastric secretion. Pharmacology (1992) 0.93

Action of some natural peptides on the stomach of the anaesthetized rat. Naunyn Schmiedebergs Arch Pharmacol (1977) 0.92

Histamine H2-antagonists modify gastric emptying in the rat. Br J Pharmacol (1982) 0.91

Effect of ranitidine and cimetidine on gastric emptying of a mixed meal in man. Int J Clin Pharmacol Ther Toxicol (1984) 0.91

Effect of histamine and related compounds on gastric emptying of the conscious rat. Pharmacology (1981) 0.90

Acetylcholine-releasing effect of gastrin and related polypeptides. Eur J Pharmacol (1972) 0.89

Cholecystokinetic activity of the new peptide caerulein in man. Gastroenterology (1969) 0.89

Effect of somatostatin and thyrotropin-releasing hormone on cholecystokinin-induced gallbladder emptying. Dig Dis Sci (1986) 0.89

Prokinetics in the treatment of gastro-oesophageal reflux disease. International symposium. Paris, France, 5 September 1996. Eur J Gastroenterol Hepatol (1998) 0.89

Effect of some new Histamine H2-receptor antagonists on the guinea-pig papillary muscle. Naunyn Schmiedebergs Arch Pharmacol (1981) 0.89

Inhibition of acetylcholine induced intestinal motility by interleukin 1 beta in the rat. Gut (1996) 0.89

Nasal absorption of caerulein. Lancet (1969) 0.88

Effect of substance P and its natural analogues on gastric emptying of the conscious rat. Br J Pharmacol (1981) 0.88

Activity of 2-(5-methyl-4-imidazolyl)-ethylamine (5-methylhistamine) on the gastric secretion of different laboratory animals and of man. Eur J Pharmacol (1974) 0.88

Histamine receptors in isolated guinea pig duodenal muscle: H3 receptors inhibit cholinergic neurotransmission. J Pharmacol Exp Ther (1991) 0.88

Bombesin delays gastric emptying in the rat. Digestion (1981) 0.88

Effect of somatostatin 14 on pure human pancreatic secretion. Dig Dis Sci (1987) 0.88

Negative inotropic effect of some H2-receptor antagonists on the isolated human atria. Experientia (1983) 0.87

Modern diagnosis of gastroesophageal reflux disease (GERD). Hepatogastroenterology (1999) 0.87

Effects of alkyl analogues of histamine and metiamide on the isolated guinea pig heart. Pharmacology (1981) 0.87

[Action of some gastric antisecretory drugs on histamine H2-receptors (author's transl)]. Ateneo Parmense Acta Biomed (1978) 0.87

Action of some natural polypeptides on the longitudinal muscle of the guinea pig ileum. Eur J Pharmacol (1977) 0.87

Effect of the new H2-receptor antagonist mifentidine on gastric acid secretion in the cat: comparison with cimetidine and ranitidine. Arch Int Pharmacodyn Ther (1985) 0.87

Current trends in the management of achalasia. Dig Liver Dis (2001) 0.87

Biological activities of a new specific stimulant of histamine H2 receptors. Farmaco Sci (1976) 0.86

Effects of natural analogues of substance P on the motility of human gastrointestinal tract in vitro. J Pharm Pharmacol (1978) 0.86

Enlargement of salivary glands in rats after chronic administration of physalaemin or isoprenaline. J Pharm Pharmacol (1966) 0.86

US power Doppler of hepatic angiomyolipoma with low fat content. Eur Radiol (2000) 0.85

Further observations on the motor activity of some new histamine H2-receptor antagonists on the digestive system. Int J Tissue React (1983) 0.85

Placebo and placebo effect: their impact on the evaluation of drug response in patients. Dig Dis (1995) 0.85

Action of histamine receptor agonists and antagonists on the rat uterus. Br J Pharmacol (1979) 0.84

Specific adaptation of gastric emptying to diets with differing protein content in the rat: is endogenous cholecystokinin implicated? Gut (1997) 0.84

Determinants of the short-term gastric damage caused by NSAIDs in man. Aliment Pharmacol Ther (2007) 0.83

Histamine H3-receptor activation inhibits acetylcholine release from the guinea pig myenteric plexus. Agents Actions (1991) 0.83

Histamine H2-receptor agonists and antagonists on pancreatic exocrine secretion of the dog. Agents Actions (1985) 0.83

Endoscopic treatment of gastro-oesophageal reflux disease (GORD): a systematic review. Dig Liver Dis (2003) 0.83